THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (SPANISH EDITION)

Transcription

1 THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (SPANISH EDITION) Feedback from 108 Spanish patient groups PUBLISHED MAY 2016

2 Nuevos tratamientos con precios que impidan el acceso para los pacientes. National Spanish patient group specialising in hepatitis and HIV/AIDS in 2016, patientview is publishing 20 corporate reputation of pharma reports, analysing the results from the 1,075 patient groups responding to the 2015 survey. specialty reports: cancer I circulatory conditions I diabetes I hiv/aids I hepatitis I neurological conditions I mental health I respiratory conditions I skin conditions I rare diseases (10 reports) geographic region reports (in addition to this current spain report): europe-wide I eastern europe I germany I global I italy I latin america I nordic I uk I us (10 reports)

3 CONTENTS ABOUT THIS REPORT Page 1 WHAT DID SPANISH PATIENT GROUPS SAY ABOUT PHARMA IN 2015? Summary of the industry-wide findings (as judged by Spanish patient groups) Page 3 A FEW COMMENTS ON THE SPANISH CORPORATE RANKINGS Page 6 WHAT CAN PHARMA COMPANIES DO TO IMPROVE THEIR CORPORATE REPUTATION? Page 7 COMMENTS FROM SPANISH PATIENT GROUPS, 2015 Page 8 CASE STUDY: PATIENT-GROUP RELATIONS AND PATIENT CENTRICITY AT... AbbVie Spain Novartis Spain Page 10 METHODOLOGY OF THE PATIENT-GROUP SURVEY Page 15 QUESTIONNAIRE FOR PHARMA COMPANIES 2015 Page 16 APPENDIX 1: Data on how Spanish patient groups see the pharmaceutical industry in 2015 Page 17 APPENDIX 2: Rankings of the 14 pharma companies for each of the 6 indicators of corporate reputation, as perceived by Spanish patient groups in 2015 Page 22 APPENDIX 3: Profiles of the 14 companies Page 31 APPENDIX 4: Profiles of the 108 respondent Spanish patient groups Page 47

4 LIST OF TABLES AND CHARTS BASED ON THE VIEWS OF SPANISH PATIENT GROUPS, 2015 Percentage of Spanish patient groups claiming familiarity with the company Page 2 Percentage of Spanish patient groups claiming familiarity with the company, and which also worked with it Page 2 Percentage of patient groups worldwide (by geographic region) stating that the GENERIC pharma industry has an Excellent or Good corporate reputation, 2015 Percentage of patient groups worldwide (by geographic region) stating that pharma is Excellent or Good at MAKING USEFUL PRODUCTS Percentage of patient groups worldwide (by geographic region) stating that pharma is Excellent or Good at PROVIDING SERVICES TO PATIENTS OUTSIDE THE BUSINESS REMIT Percentage of patient groups worldwide (by geographic region) stating that pharma is Excellent or Good at HAVING FAIR PRICING POLICIES Final ranking of 14 pharma companies in Spain, 2015, according to Spanish patient groups (v. final ranking of 7 pharma companies in Spain, 2014) If a pharma company wishes to improve its corporate reputation with patients and patient groups, which single strategy from the list below do you think would be MOST IMPORTANT for the company to follow? Please select only ONE option How do you think your organisation s members (or the people you represent) would rate the corporate reputation of the following healthcare sectors in 2015? Page 3 Page 5 Page 5 Page 5 Page 6 Page 7 Page 18 What do you think has happened to the corporate reputation of the pharma industry over the past five years? Page 19 How good or bad do you think the pharma industry is in 2015 at carrying out the following activities (all of which influence their corporate standing with patients and patient groups)? Page 20 How good or bad do you think the pharma industry is in 2015 at carrying out the following activities (all of which influence their corporate standing with patients and patient groups)? Page 21 Companies with the most effective patient-centred strategy (rankings of 14 companies, 2015) Page 23 Companies providing the best high-quality patient information (rankings of 14 companies, 2015) Page 24 Companies with the best record on patient safety (rankings of 14 companies, 2015) Page 25 Companies with the most-useful high-quality products (rankings of 14 companies, 2015) Page 26 Companies with the best record of transparency (rankings of 14 companies, 2015) Page 27 Companies with the best record on integrity (rankings of 14 companies, 2015) Page 28 Rankings of the 14 pharmaceutical companies in 2015, ALPHABETIC ORDER Page 29 Rankings of the 14 pharmaceutical companies in 2015, HIGHEST TO LOWEST Page 30 Main specialisations of 2015 s 108 respondent Spanish patient groups Page 48 Geographic remit of 2015 s 108 respondent Spanish patient groups Page 48

5 LIST OF TABLES AND CHARTS CONTINUED AbbVie page 33 AstraZeneca page 36 Bayer page 37 Boehringer Ingelheim page 38 B-MS page 39 Eli Lilly page 41 Gilead Sciences page GSK page 42 Janssen page 43 Merck & Co (US) page 45 Novartis page 46 Pfizer page 47 Roche page 48 Sanofi page 50 profiles of the 14 companies, according to the spanish patient groups familiar with these companies, or which have worked with them Each profile contains... company background information Annual revenue (latest-available year), comprising amount in currency, as quoted by the profiled company itself. = increase in revenue over the previous year or = decrease in revenue. The profiled company s main treatment subject areas (and areas of R&D). A mission statement from the profiled company. how the company has performed at six indicators of corporate reputation The profiled company s performance at the six indicators of corporate reputation in 2015, according to the Spanish patient groups familiar with the company. The profiled company s performance at the six indicators of corporate reputation, according to the Spanish patient groups that have worked with the company. How the profiled company performed among Spanish patient groups for different therapy areas, compared with the company s global averages for Spanish patient groups in how the company ranks for corporate reputation compared with other companies The profiled company s rankings among Spanish patient groups in 2015 for the six indicators of corporate reputation, compared with 13 other companies. The profiled company s rankings worldwide in 2015 for the six indicators of corporate reputation, compared with 47 other companies. profile of the patient groups familiar with the company Other companies that partner with a significant number of the profiled company s partner patient groups. The countries of the patient groups familiar with the profiled company. Janssen Pharmaceutical Companies of Johnson & Johnson

6 Contact details PatientView Registered office: One Fleet Place, London, EC4M 7WS, UK Tel: +44-(0) Registered in England, number: Data protection registration number: Z VAT registration number: GB Copyright 2016 PatientView Ltd. All rights reserved. This booklet is the property of PatientView, and no part may be reproduced without permission, or passed on to any third party without the permission of PatientView.